Nasonex and Alendronic acid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nasonex (mometasone furoate monohydrate) and Alendronic acid (alendronate sodium). Common drug interactions include coma among females and constipation among males.

The phase IV clinical study analyzes what interactions people have when they take Nasonex and Alendronic acid. It is created by eHealthMe based on reports of 94 people who take the same drugs from the FDA, and is updated regularly.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.

What is Alendronic acid?

Alendronic acid has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 18,408 Alendronic acid users. Check the latest studies of Alendronic acid.



On Jul, 08, 2026

94 people who take Nasonex and Alendronic acid together, and have interactions are studied.

Nasonex and Alendronic acid drug interactions.

What are the common drug interactions of Nasonex and Alendronic Acid, by gender? *:

female:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Teeth brittle (other half has a defect in the teeth)
  6. Tooth injury
  7. Alopecia (absence of hair from areas of the body)
  8. Arthralgia (joint pain)
  9. Asthenia (weakness)
  10. Asthma

male:

  1. Constipation
  2. Cough
  3. Drug ineffective
  4. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Head discomfort
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Immunosuppressant drug level decreased
  9. Left ventricular dysfunction
  10. Muscular weakness (muscle weakness)

What are the common drug interactions of Nasonex and Alendronic Acid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Balance disorder
  2. Dizziness
  3. Head discomfort
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Muscular weakness (muscle weakness)
  6. Neurological symptom (symptoms of nervous system disease)

40-49:

  1. Acute pulmonary oedema (sudden deposit of fluid in the lung))
  2. Cardiomegaly (increased size of heart than normal)
  3. Left ventricular dysfunction

50-59:

  1. Teeth brittle (other half has a defect in the teeth)
  2. Tooth injury
  3. Skin plaque (red, scaly patches to appear on the skin)

60+:

  1. Coma (state of unconsciousness lasting more than six hours)
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Arthralgia (joint pain)
  4. Asthenia (weakness)
  5. Asthma
  6. Balance disorder
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Dyspnoea (difficult or laboured respiration)
  9. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  10. Flatulence (flatus expelled through the anus)

What are the existing conditions these people have? *

  1. Pain: 55 people, 58.51%
  2. Cardiac Failure: 7 people, 7.45%

* Approximation only. Some reports may have incomplete information.

Do you take Nasonex and Alendronic acid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nasonex and Alendronic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nasonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Alendronic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nasonex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alendronic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate monohydrate and alendronate sodium (the active ingredients of Nasonex and Alendronic acid, respectively), and Nasonex and Alendronic acid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: